The Fight Against Coronavirus (COVID-19)

This is an intro to principles and working together. It is critical to continue to emphasize PhrMA member commitment. This should align with the tracker in intro, sub-topics of R&D and link to the tracker. And this should provide a platform for curated voice (e.g. access to blogs, videos other across the site).

We Are Committed to Act, Treat and Defend

America’s biopharmaceutical companies are coming together to achieve one common goal: ending COVID-19. Our shared heritage of discovery and research allows us to respond to the coronavirus swiftly, with active trials for both treatments and vaccines already underway. For decades, we’ve continuously pushed the boundaries of science, investing in new technology, research and treatments that help advance medicine. From dedicating top scientists and investments toward research to sharing learnings in real-time, we’re putting our energy into finding a vaccine for the coronavirus as fast as possible. But it doesn’t stop there. We’re also working to expand manufacturing capabilities, increase testing and provide financial support to ensure that access to these lifesaving treatments will be available to everyone.

Together, we stand committed to treat and defend against disease in all its forms, not just COVID-19.